Forte Capital LLC ADV Sells 1,484 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Forte Capital LLC ADV trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 36,303 shares of the medical equipment provider’s stock after selling 1,484 shares during the period. Intuitive Surgical comprises 2.1% of Forte Capital LLC ADV’s holdings, making the stock its 12th biggest holding. Forte Capital LLC ADV’s holdings in Intuitive Surgical were worth $18,949,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $36,000. Sierra Ocean LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $40,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $38,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ISRG. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 0.3 %

Shares of Intuitive Surgical stock opened at $606.57 on Friday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $216.05 billion, a price-to-earnings ratio of 94.63, a PEG ratio of 5.79 and a beta of 1.39. The firm’s 50 day simple moving average is $564.41 and its two-hundred day simple moving average is $523.46.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.